Actor/singer Nicolette Robinson and her husband, "Hamilton" musical star Leslie Odom Jr., wrote an original song set to the heartbeat of Robinson's father, who survived a heart attack. The song, "Second Chance," is featured in a campaign for Bayer Aspirin focused on how a heart attack can affect families.
-- Sandra Mackey, chief marketing officer at Bon Secours Mercy Health in Cincinnati, commenting in a Becker's Health IT story about hospital rebranding.
DCN Dx has purchased PortaScience, a point-of-care diagnostics company in Moorestown, N.J., for an undisclosed amount. DCN said the acquisition will allow PortaScience customers to access various contract assay development services, such as lateral flow immunoassay and microfluidic formats.
Hologic has closed on its acquisition of Mobidiag Oy with an approximately $808 million enterprise value. Hologic has also announced three other acquisitions this year related to women's health products, purchasing Somatex, Biotheranostics and Diagenode.
23andMe has merged with VG Acquisition Corp. and has debuted on the Nasdaq stock exchange. Shares rose 22% upon closing of the deal, which has brought in $592 million in gross proceeds so far that 23andMe can use to expand its consumer health and therapeutics businesses.
Researchers from the University of Illinois Chicago have developed a fast COVID-19 test using graphene sheets. The sheets are studded with antibodies that will bind to the coronavirus' spike protein, causing molecular vibrations that are picked up by a motion detector in less than five minutes.
Scientists from Scotland's Edinburgh University are developing a new COVID-19 test that uses saliva samples instead of nasal and throat swabs. The test can produce results within 24 hours.
NIH researchers have developed a prototype oxygen sensor that can diagnose pregnancy complications. The device uses near-infrared light to measure oxygen levels in the placenta's arterial and venous network.
HelixBind has received a $3 million federal grant from the NIH, which the company will use to develop and market its RaPID/BSI sepsis test. The test, which was granted breakthrough status by the FDA last year, diagnoses bloodstream infections associated with sepsis.
- Page 1